Apotex, Mylan Urge Full Fed. Circ. To Ax Cancer Drug Patent
Apotex and Mylan have asked the full Federal Circuit to reconsider a panel's decision refusing to invalidate patents for Teva's cancer drug Bendeka, saying the patents don't hold up and the...To view the full article, register now.
Already a subscriber? Click here to view full article